nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—PDE4C—forebrain—Alzheimer's disease	0.0142	0.121	CbGeAlD
Roflumilast—Haematochezia—Rivastigmine—Alzheimer's disease	0.0138	0.0228	CcSEcCtD
Roflumilast—Completed suicide—Galantamine—Alzheimer's disease	0.0137	0.0226	CcSEcCtD
Roflumilast—PDE4C—telencephalon—Alzheimer's disease	0.0131	0.111	CbGeAlD
Roflumilast—Pancreatitis acute—Memantine—Alzheimer's disease	0.0123	0.0203	CcSEcCtD
Roflumilast—PDE4D—telencephalon—Alzheimer's disease	0.0115	0.0978	CbGeAlD
Roflumilast—Suicidal ideation—Galantamine—Alzheimer's disease	0.0115	0.019	CcSEcCtD
Roflumilast—PDE4A—telencephalon—Alzheimer's disease	0.0102	0.0865	CbGeAlD
Roflumilast—Completed suicide—Memantine—Alzheimer's disease	0.00965	0.0159	CcSEcCtD
Roflumilast—Suicidal ideation—Memantine—Alzheimer's disease	0.00809	0.0134	CcSEcCtD
Roflumilast—Suicidal ideation—Rivastigmine—Alzheimer's disease	0.00791	0.0131	CcSEcCtD
Roflumilast—PDE4C—nervous system—Alzheimer's disease	0.00772	0.0656	CbGeAlD
Roflumilast—PDE4C—central nervous system—Alzheimer's disease	0.00743	0.0631	CbGeAlD
Roflumilast—Gamma-glutamyltransferase increased—Memantine—Alzheimer's disease	0.00689	0.0114	CcSEcCtD
Roflumilast—Endocrine disorder—Memantine—Alzheimer's disease	0.00684	0.0113	CcSEcCtD
Roflumilast—PDE4B—forebrain—Alzheimer's disease	0.0066	0.0561	CbGeAlD
Roflumilast—PDE4D—cerebellum—Alzheimer's disease	0.00639	0.0543	CbGeAlD
Roflumilast—Gastrooesophageal reflux disease—Memantine—Alzheimer's disease	0.00628	0.0104	CcSEcCtD
Roflumilast—Atrial fibrillation—Galantamine—Alzheimer's disease	0.00617	0.0102	CcSEcCtD
Roflumilast—Gastrooesophageal reflux disease—Rivastigmine—Alzheimer's disease	0.00614	0.0101	CcSEcCtD
Roflumilast—PDE4B—telencephalon—Alzheimer's disease	0.00607	0.0516	CbGeAlD
Roflumilast—PDE4C—brain—Alzheimer's disease	0.0059	0.0501	CbGeAlD
Roflumilast—PDE4A—cerebellum—Alzheimer's disease	0.00566	0.0481	CbGeAlD
Roflumilast—PDE4D—brain—Alzheimer's disease	0.00519	0.0441	CbGeAlD
Roflumilast—Gastritis—Galantamine—Alzheimer's disease	0.00518	0.00856	CcSEcCtD
Roflumilast—Atrial fibrillation—Donepezil—Alzheimer's disease	0.00479	0.00791	CcSEcCtD
Roflumilast—PDE4A—brain—Alzheimer's disease	0.00459	0.039	CbGeAlD
Roflumilast—Weight decreased—Galantamine—Alzheimer's disease	0.00458	0.00756	CcSEcCtD
Roflumilast—Pneumonia—Galantamine—Alzheimer's disease	0.00454	0.00749	CcSEcCtD
Roflumilast—Depression—Galantamine—Alzheimer's disease	0.0045	0.00743	CcSEcCtD
Roflumilast—Renal failure acute—Memantine—Alzheimer's disease	0.00446	0.00737	CcSEcCtD
Roflumilast—Urinary tract infection—Galantamine—Alzheimer's disease	0.00438	0.00724	CcSEcCtD
Roflumilast—Renal failure acute—Rivastigmine—Alzheimer's disease	0.00436	0.00721	CcSEcCtD
Roflumilast—Atrial fibrillation—Memantine—Alzheimer's disease	0.00434	0.00718	CcSEcCtD
Roflumilast—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.00426	0.00705	CcSEcCtD
Roflumilast—Atrial fibrillation—Rivastigmine—Alzheimer's disease	0.00425	0.00702	CcSEcCtD
Roflumilast—Rhinitis—Galantamine—Alzheimer's disease	0.00406	0.0067	CcSEcCtD
Roflumilast—Gastritis—Donepezil—Alzheimer's disease	0.00401	0.00663	CcSEcCtD
Roflumilast—Connective tissue disorder—Galantamine—Alzheimer's disease	0.00398	0.00657	CcSEcCtD
Roflumilast—Influenza—Donepezil—Alzheimer's disease	0.00392	0.00648	CcSEcCtD
Roflumilast—Cardiac disorder—Galantamine—Alzheimer's disease	0.00376	0.00621	CcSEcCtD
Roflumilast—Immune system disorder—Galantamine—Alzheimer's disease	0.00366	0.00604	CcSEcCtD
Roflumilast—Gastritis—Memantine—Alzheimer's disease	0.00364	0.00602	CcSEcCtD
Roflumilast—PDE4B—nervous system—Alzheimer's disease	0.00358	0.0305	CbGeAlD
Roflumilast—Gastritis—Rivastigmine—Alzheimer's disease	0.00356	0.00589	CcSEcCtD
Roflumilast—Influenza—Memantine—Alzheimer's disease	0.00356	0.00588	CcSEcCtD
Roflumilast—Mental disorder—Galantamine—Alzheimer's disease	0.00355	0.00586	CcSEcCtD
Roflumilast—Weight decreased—Donepezil—Alzheimer's disease	0.00355	0.00586	CcSEcCtD
Roflumilast—Malnutrition—Galantamine—Alzheimer's disease	0.00352	0.00582	CcSEcCtD
Roflumilast—Pneumonia—Donepezil—Alzheimer's disease	0.00351	0.00581	CcSEcCtD
Roflumilast—Infestation NOS—Donepezil—Alzheimer's disease	0.00349	0.00577	CcSEcCtD
Roflumilast—Infestation—Donepezil—Alzheimer's disease	0.00349	0.00577	CcSEcCtD
Roflumilast—Depression—Donepezil—Alzheimer's disease	0.00348	0.00576	CcSEcCtD
Roflumilast—Tension—Galantamine—Alzheimer's disease	0.00346	0.00571	CcSEcCtD
Roflumilast—Dysgeusia—Galantamine—Alzheimer's disease	0.00345	0.0057	CcSEcCtD
Roflumilast—PDE4B—central nervous system—Alzheimer's disease	0.00345	0.0293	CbGeAlD
Roflumilast—Nervousness—Galantamine—Alzheimer's disease	0.00342	0.00565	CcSEcCtD
Roflumilast—Back pain—Galantamine—Alzheimer's disease	0.00341	0.00563	CcSEcCtD
Roflumilast—Urinary tract infection—Donepezil—Alzheimer's disease	0.0034	0.00561	CcSEcCtD
Roflumilast—Muscle spasms—Galantamine—Alzheimer's disease	0.00339	0.0056	CcSEcCtD
Roflumilast—PDE4B—cerebellum—Alzheimer's disease	0.00337	0.0287	CbGeAlD
Roflumilast—Tremor—Galantamine—Alzheimer's disease	0.0033	0.00545	CcSEcCtD
Roflumilast—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00327	0.0054	CcSEcCtD
Roflumilast—Weight decreased—Memantine—Alzheimer's disease	0.00322	0.00532	CcSEcCtD
Roflumilast—Pneumonia—Memantine—Alzheimer's disease	0.00319	0.00527	CcSEcCtD
Roflumilast—Malaise—Galantamine—Alzheimer's disease	0.00318	0.00525	CcSEcCtD
Roflumilast—Infestation NOS—Memantine—Alzheimer's disease	0.00317	0.00524	CcSEcCtD
Roflumilast—Infestation—Memantine—Alzheimer's disease	0.00317	0.00524	CcSEcCtD
Roflumilast—Vertigo—Galantamine—Alzheimer's disease	0.00317	0.00523	CcSEcCtD
Roflumilast—Depression—Memantine—Alzheimer's disease	0.00316	0.00523	CcSEcCtD
Roflumilast—Weight decreased—Rivastigmine—Alzheimer's disease	0.00315	0.0052	CcSEcCtD
Roflumilast—Rhinitis—Donepezil—Alzheimer's disease	0.00315	0.0052	CcSEcCtD
Roflumilast—Pneumonia—Rivastigmine—Alzheimer's disease	0.00312	0.00516	CcSEcCtD
Roflumilast—Palpitations—Galantamine—Alzheimer's disease	0.00311	0.00514	CcSEcCtD
Roflumilast—Infestation NOS—Rivastigmine—Alzheimer's disease	0.0031	0.00513	CcSEcCtD
Roflumilast—Infestation—Rivastigmine—Alzheimer's disease	0.0031	0.00513	CcSEcCtD
Roflumilast—Depression—Rivastigmine—Alzheimer's disease	0.0031	0.00511	CcSEcCtD
Roflumilast—Urinary tract infection—Memantine—Alzheimer's disease	0.00308	0.0051	CcSEcCtD
Roflumilast—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.00302	0.00498	CcSEcCtD
Roflumilast—Hepatobiliary disease—Memantine—Alzheimer's disease	0.003	0.00496	CcSEcCtD
Roflumilast—Myalgia—Galantamine—Alzheimer's disease	0.003	0.00496	CcSEcCtD
Roflumilast—Anxiety—Galantamine—Alzheimer's disease	0.00299	0.00494	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00298	0.00492	CcSEcCtD
Roflumilast—Sinusitis—Memantine—Alzheimer's disease	0.00298	0.00492	CcSEcCtD
Roflumilast—Discomfort—Galantamine—Alzheimer's disease	0.00296	0.0049	CcSEcCtD
Roflumilast—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.00294	0.00485	CcSEcCtD
Roflumilast—Sinusitis—Rivastigmine—Alzheimer's disease	0.00291	0.00481	CcSEcCtD
Roflumilast—Rhinitis—Memantine—Alzheimer's disease	0.00286	0.00472	CcSEcCtD
Roflumilast—Nervous system disorder—Galantamine—Alzheimer's disease	0.00282	0.00466	CcSEcCtD
Roflumilast—Connective tissue disorder—Memantine—Alzheimer's disease	0.0028	0.00462	CcSEcCtD
Roflumilast—Rhinitis—Rivastigmine—Alzheimer's disease	0.00279	0.00462	CcSEcCtD
Roflumilast—Skin disorder—Galantamine—Alzheimer's disease	0.00279	0.00462	CcSEcCtD
Roflumilast—Mental disorder—Donepezil—Alzheimer's disease	0.00275	0.00454	CcSEcCtD
Roflumilast—PDE4B—brain—Alzheimer's disease	0.00274	0.0233	CbGeAlD
Roflumilast—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00274	0.00452	CcSEcCtD
Roflumilast—Malnutrition—Donepezil—Alzheimer's disease	0.00273	0.00451	CcSEcCtD
Roflumilast—Tension—Donepezil—Alzheimer's disease	0.00268	0.00443	CcSEcCtD
Roflumilast—Dysgeusia—Donepezil—Alzheimer's disease	0.00267	0.00442	CcSEcCtD
Roflumilast—Nervousness—Donepezil—Alzheimer's disease	0.00265	0.00438	CcSEcCtD
Roflumilast—Cardiac disorder—Memantine—Alzheimer's disease	0.00264	0.00437	CcSEcCtD
Roflumilast—Back pain—Donepezil—Alzheimer's disease	0.00264	0.00436	CcSEcCtD
Roflumilast—Muscle spasms—Donepezil—Alzheimer's disease	0.00263	0.00434	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00262	0.00433	CcSEcCtD
Roflumilast—Insomnia—Galantamine—Alzheimer's disease	0.0026	0.0043	CcSEcCtD
Roflumilast—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00259	0.00427	CcSEcCtD
Roflumilast—Immune system disorder—Memantine—Alzheimer's disease	0.00257	0.00425	CcSEcCtD
Roflumilast—Mediastinal disorder—Memantine—Alzheimer's disease	0.00257	0.00424	CcSEcCtD
Roflumilast—Tremor—Donepezil—Alzheimer's disease	0.00256	0.00423	CcSEcCtD
Roflumilast—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00253	0.00419	CcSEcCtD
Roflumilast—Dyspepsia—Galantamine—Alzheimer's disease	0.00253	0.00418	CcSEcCtD
Roflumilast—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00251	0.00415	CcSEcCtD
Roflumilast—Decreased appetite—Galantamine—Alzheimer's disease	0.0025	0.00413	CcSEcCtD
Roflumilast—Mental disorder—Memantine—Alzheimer's disease	0.0025	0.00412	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00248	0.0041	CcSEcCtD
Roflumilast—Malnutrition—Memantine—Alzheimer's disease	0.00248	0.0041	CcSEcCtD
Roflumilast—Fatigue—Galantamine—Alzheimer's disease	0.00248	0.0041	CcSEcCtD
Roflumilast—Malaise—Donepezil—Alzheimer's disease	0.00246	0.00407	CcSEcCtD
Roflumilast—Constipation—Galantamine—Alzheimer's disease	0.00246	0.00406	CcSEcCtD
Roflumilast—Vertigo—Donepezil—Alzheimer's disease	0.00245	0.00405	CcSEcCtD
Roflumilast—Mental disorder—Rivastigmine—Alzheimer's disease	0.00244	0.00403	CcSEcCtD
Roflumilast—Tension—Memantine—Alzheimer's disease	0.00243	0.00402	CcSEcCtD
Roflumilast—Dysgeusia—Memantine—Alzheimer's disease	0.00243	0.00401	CcSEcCtD
Roflumilast—Malnutrition—Rivastigmine—Alzheimer's disease	0.00243	0.00401	CcSEcCtD
Roflumilast—Nervousness—Memantine—Alzheimer's disease	0.00241	0.00398	CcSEcCtD
Roflumilast—Back pain—Memantine—Alzheimer's disease	0.0024	0.00396	CcSEcCtD
Roflumilast—Tension—Rivastigmine—Alzheimer's disease	0.00238	0.00393	CcSEcCtD
Roflumilast—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00238	0.00392	CcSEcCtD
Roflumilast—Feeling abnormal—Galantamine—Alzheimer's disease	0.00237	0.00392	CcSEcCtD
Roflumilast—Nervousness—Rivastigmine—Alzheimer's disease	0.00236	0.00389	CcSEcCtD
Roflumilast—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00235	0.00389	CcSEcCtD
Roflumilast—Back pain—Rivastigmine—Alzheimer's disease	0.00235	0.00388	CcSEcCtD
Roflumilast—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00233	0.00385	CcSEcCtD
Roflumilast—Myalgia—Donepezil—Alzheimer's disease	0.00232	0.00384	CcSEcCtD
Roflumilast—Tremor—Memantine—Alzheimer's disease	0.00232	0.00384	CcSEcCtD
Roflumilast—Anxiety—Donepezil—Alzheimer's disease	0.00232	0.00383	CcSEcCtD
Roflumilast—Ill-defined disorder—Memantine—Alzheimer's disease	0.0023	0.0038	CcSEcCtD
Roflumilast—Discomfort—Donepezil—Alzheimer's disease	0.0023	0.0038	CcSEcCtD
Roflumilast—Abdominal pain—Galantamine—Alzheimer's disease	0.00227	0.00376	CcSEcCtD
Roflumilast—Tremor—Rivastigmine—Alzheimer's disease	0.00227	0.00375	CcSEcCtD
Roflumilast—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00225	0.00372	CcSEcCtD
Roflumilast—Malaise—Memantine—Alzheimer's disease	0.00224	0.00369	CcSEcCtD
Roflumilast—Vertigo—Memantine—Alzheimer's disease	0.00223	0.00368	CcSEcCtD
Roflumilast—Infection—Donepezil—Alzheimer's disease	0.00221	0.00366	CcSEcCtD
Roflumilast—Palpitations—Memantine—Alzheimer's disease	0.00219	0.00362	CcSEcCtD
Roflumilast—Malaise—Rivastigmine—Alzheimer's disease	0.00219	0.00361	CcSEcCtD
Roflumilast—Nervous system disorder—Donepezil—Alzheimer's disease	0.00219	0.00361	CcSEcCtD
Roflumilast—Vertigo—Rivastigmine—Alzheimer's disease	0.00218	0.0036	CcSEcCtD
Roflumilast—Palpitations—Rivastigmine—Alzheimer's disease	0.00214	0.00354	CcSEcCtD
Roflumilast—Hypersensitivity—Galantamine—Alzheimer's disease	0.00212	0.0035	CcSEcCtD
Roflumilast—Myalgia—Memantine—Alzheimer's disease	0.00211	0.00349	CcSEcCtD
Roflumilast—Anxiety—Memantine—Alzheimer's disease	0.0021	0.00348	CcSEcCtD
Roflumilast—Discomfort—Memantine—Alzheimer's disease	0.00209	0.00345	CcSEcCtD
Roflumilast—Myalgia—Rivastigmine—Alzheimer's disease	0.00207	0.00341	CcSEcCtD
Roflumilast—Asthenia—Galantamine—Alzheimer's disease	0.00206	0.00341	CcSEcCtD
Roflumilast—Anxiety—Rivastigmine—Alzheimer's disease	0.00206	0.0034	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00205	0.00339	CcSEcCtD
Roflumilast—Discomfort—Rivastigmine—Alzheimer's disease	0.00204	0.00337	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00203	0.00335	CcSEcCtD
Roflumilast—Insomnia—Donepezil—Alzheimer's disease	0.00202	0.00333	CcSEcCtD
Roflumilast—Infection—Memantine—Alzheimer's disease	0.00201	0.00332	CcSEcCtD
Roflumilast—Nervous system disorder—Memantine—Alzheimer's disease	0.00198	0.00328	CcSEcCtD
Roflumilast—Diarrhoea—Galantamine—Alzheimer's disease	0.00197	0.00325	CcSEcCtD
Roflumilast—Infection—Rivastigmine—Alzheimer's disease	0.00197	0.00325	CcSEcCtD
Roflumilast—Skin disorder—Memantine—Alzheimer's disease	0.00197	0.00325	CcSEcCtD
Roflumilast—Dyspepsia—Donepezil—Alzheimer's disease	0.00196	0.00324	CcSEcCtD
Roflumilast—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00194	0.00321	CcSEcCtD
Roflumilast—Decreased appetite—Donepezil—Alzheimer's disease	0.00194	0.0032	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00192	0.00318	CcSEcCtD
Roflumilast—Skin disorder—Rivastigmine—Alzheimer's disease	0.00192	0.00318	CcSEcCtD
Roflumilast—Fatigue—Donepezil—Alzheimer's disease	0.00192	0.00317	CcSEcCtD
Roflumilast—Constipation—Donepezil—Alzheimer's disease	0.00191	0.00315	CcSEcCtD
Roflumilast—Dizziness—Galantamine—Alzheimer's disease	0.0019	0.00314	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00184	0.00305	CcSEcCtD
Roflumilast—Feeling abnormal—Donepezil—Alzheimer's disease	0.00184	0.00303	CcSEcCtD
Roflumilast—Insomnia—Memantine—Alzheimer's disease	0.00183	0.00302	CcSEcCtD
Roflumilast—Vomiting—Galantamine—Alzheimer's disease	0.00183	0.00302	CcSEcCtD
Roflumilast—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00182	0.00301	CcSEcCtD
Roflumilast—Rash—Galantamine—Alzheimer's disease	0.00181	0.003	CcSEcCtD
Roflumilast—Dermatitis—Galantamine—Alzheimer's disease	0.00181	0.00299	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.0018	0.00298	CcSEcCtD
Roflumilast—Headache—Galantamine—Alzheimer's disease	0.0018	0.00298	CcSEcCtD
Roflumilast—Insomnia—Rivastigmine—Alzheimer's disease	0.00179	0.00296	CcSEcCtD
Roflumilast—Dyspepsia—Memantine—Alzheimer's disease	0.00178	0.00294	CcSEcCtD
Roflumilast—Urticaria—Donepezil—Alzheimer's disease	0.00177	0.00293	CcSEcCtD
Roflumilast—Abdominal pain—Donepezil—Alzheimer's disease	0.00176	0.00291	CcSEcCtD
Roflumilast—Decreased appetite—Memantine—Alzheimer's disease	0.00176	0.00291	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00175	0.00289	CcSEcCtD
Roflumilast—Fatigue—Memantine—Alzheimer's disease	0.00174	0.00288	CcSEcCtD
Roflumilast—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00174	0.00288	CcSEcCtD
Roflumilast—Constipation—Memantine—Alzheimer's disease	0.00173	0.00286	CcSEcCtD
Roflumilast—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00172	0.00284	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00171	0.00282	CcSEcCtD
Roflumilast—Nausea—Galantamine—Alzheimer's disease	0.00171	0.00282	CcSEcCtD
Roflumilast—Fatigue—Rivastigmine—Alzheimer's disease	0.00171	0.00282	CcSEcCtD
Roflumilast—Constipation—Rivastigmine—Alzheimer's disease	0.00169	0.0028	CcSEcCtD
Roflumilast—Feeling abnormal—Memantine—Alzheimer's disease	0.00167	0.00276	CcSEcCtD
Roflumilast—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00165	0.00273	CcSEcCtD
Roflumilast—Hypersensitivity—Donepezil—Alzheimer's disease	0.00164	0.00271	CcSEcCtD
Roflumilast—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00163	0.0027	CcSEcCtD
Roflumilast—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00162	0.00267	CcSEcCtD
Roflumilast—Urticaria—Memantine—Alzheimer's disease	0.00161	0.00266	CcSEcCtD
Roflumilast—Abdominal pain—Memantine—Alzheimer's disease	0.0016	0.00264	CcSEcCtD
Roflumilast—Asthenia—Donepezil—Alzheimer's disease	0.0016	0.00264	CcSEcCtD
Roflumilast—Urticaria—Rivastigmine—Alzheimer's disease	0.00157	0.0026	CcSEcCtD
Roflumilast—Abdominal pain—Rivastigmine—Alzheimer's disease	0.00156	0.00259	CcSEcCtD
Roflumilast—Diarrhoea—Donepezil—Alzheimer's disease	0.00152	0.00252	CcSEcCtD
Roflumilast—Hypersensitivity—Memantine—Alzheimer's disease	0.00149	0.00246	CcSEcCtD
Roflumilast—Dizziness—Donepezil—Alzheimer's disease	0.00147	0.00243	CcSEcCtD
Roflumilast—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00146	0.00241	CcSEcCtD
Roflumilast—Asthenia—Memantine—Alzheimer's disease	0.00145	0.0024	CcSEcCtD
Roflumilast—Asthenia—Rivastigmine—Alzheimer's disease	0.00142	0.00235	CcSEcCtD
Roflumilast—Vomiting—Donepezil—Alzheimer's disease	0.00142	0.00234	CcSEcCtD
Roflumilast—Rash—Donepezil—Alzheimer's disease	0.00141	0.00232	CcSEcCtD
Roflumilast—Dermatitis—Donepezil—Alzheimer's disease	0.0014	0.00232	CcSEcCtD
Roflumilast—Headache—Donepezil—Alzheimer's disease	0.0014	0.00231	CcSEcCtD
Roflumilast—Diarrhoea—Memantine—Alzheimer's disease	0.00138	0.00229	CcSEcCtD
Roflumilast—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00135	0.00224	CcSEcCtD
Roflumilast—Dizziness—Memantine—Alzheimer's disease	0.00134	0.00221	CcSEcCtD
Roflumilast—Nausea—Donepezil—Alzheimer's disease	0.00132	0.00219	CcSEcCtD
Roflumilast—Dizziness—Rivastigmine—Alzheimer's disease	0.00131	0.00216	CcSEcCtD
Roflumilast—Vomiting—Memantine—Alzheimer's disease	0.00129	0.00213	CcSEcCtD
Roflumilast—Rash—Memantine—Alzheimer's disease	0.00128	0.00211	CcSEcCtD
Roflumilast—Dermatitis—Memantine—Alzheimer's disease	0.00127	0.00211	CcSEcCtD
Roflumilast—Headache—Memantine—Alzheimer's disease	0.00127	0.00209	CcSEcCtD
Roflumilast—Vomiting—Rivastigmine—Alzheimer's disease	0.00126	0.00208	CcSEcCtD
Roflumilast—Rash—Rivastigmine—Alzheimer's disease	0.00125	0.00206	CcSEcCtD
Roflumilast—Dermatitis—Rivastigmine—Alzheimer's disease	0.00125	0.00206	CcSEcCtD
Roflumilast—Headache—Rivastigmine—Alzheimer's disease	0.00124	0.00205	CcSEcCtD
Roflumilast—Nausea—Memantine—Alzheimer's disease	0.0012	0.00199	CcSEcCtD
Roflumilast—Nausea—Rivastigmine—Alzheimer's disease	0.00118	0.00194	CcSEcCtD
Roflumilast—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—Alzheimer's disease	0.000257	0.000927	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GAL—Alzheimer's disease	0.000256	0.000923	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GFAP—Alzheimer's disease	0.000256	0.000923	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NCSTN—Alzheimer's disease	0.000256	0.000923	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000255	0.000922	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—APP—Alzheimer's disease	0.000255	0.00092	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PSEN2—Alzheimer's disease	0.000251	0.000905	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—LRP1—Alzheimer's disease	0.000249	0.0009	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PSENEN—Alzheimer's disease	0.000246	0.000889	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GAL—Alzheimer's disease	0.000244	0.000879	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GFAP—Alzheimer's disease	0.000244	0.000879	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APH1A—Alzheimer's disease	0.000243	0.000877	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000242	0.000873	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PLCB1—Alzheimer's disease	0.00024	0.000868	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000237	0.000855	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NCSTN—Alzheimer's disease	0.000237	0.000854	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000232	0.000837	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NPY—Alzheimer's disease	0.000231	0.000833	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—LRP1—Alzheimer's disease	0.000231	0.000833	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IAPP—Alzheimer's disease	0.000229	0.000828	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—A2M—Alzheimer's disease	0.000225	0.000814	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GAL—Alzheimer's disease	0.000225	0.000813	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GFAP—Alzheimer's disease	0.000225	0.000813	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CRH—Alzheimer's disease	0.000223	0.000804	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000222	0.000802	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—CCR5—Alzheimer's disease	0.00022	0.000793	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PSEN2—Alzheimer's disease	0.000218	0.000788	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000215	0.000776	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—A2M—Alzheimer's disease	0.000215	0.000775	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000212	0.000764	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NPS—Alzheimer's disease	0.000211	0.000762	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000211	0.00076	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PPP3CA—Alzheimer's disease	0.00021	0.000758	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PSEN2—Alzheimer's disease	0.000208	0.00075	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—F2—Alzheimer's disease	0.000208	0.000749	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PTK2B—Alzheimer's disease	0.000207	0.000747	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000206	0.000744	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000202	0.000729	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GAB2—Alzheimer's disease	0.000201	0.000727	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—SST—Alzheimer's disease	0.000201	0.000727	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NTRK2—Alzheimer's disease	0.000201	0.000727	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NPY—Alzheimer's disease	0.000201	0.000725	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—CALM1—Alzheimer's disease	0.000201	0.000724	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—CCR5—Alzheimer's disease	0.0002	0.000724	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IAPP—Alzheimer's disease	0.0002	0.000721	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GSK3A—Alzheimer's disease	0.0002	0.000721	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—A2M—Alzheimer's disease	0.000199	0.000717	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—APP—Alzheimer's disease	0.000196	0.000709	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000196	0.000708	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000196	0.000707	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CRH—Alzheimer's disease	0.000194	0.0007	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PSEN2—Alzheimer's disease	0.000192	0.000694	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000192	0.000694	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NPY—Alzheimer's disease	0.000191	0.00069	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—CCR5—Alzheimer's disease	0.000191	0.00069	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IAPP—Alzheimer's disease	0.00019	0.000686	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—F2—Alzheimer's disease	0.000189	0.00068	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000187	0.000676	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000186	0.00067	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PLCB1—Alzheimer's disease	0.000185	0.000669	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CRH—Alzheimer's disease	0.000185	0.000666	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NPS—Alzheimer's disease	0.000184	0.000663	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000183	0.00066	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—CCR5—Alzheimer's disease	0.000182	0.000657	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000182	0.000655	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—F2—Alzheimer's disease	0.000181	0.000652	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PTK2B—Alzheimer's disease	0.00018	0.000651	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000178	0.000643	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000178	0.000642	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NPY—Alzheimer's disease	0.000177	0.000639	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IAPP—Alzheimer's disease	0.000176	0.000635	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NTRK2—Alzheimer's disease	0.000175	0.000633	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SST—Alzheimer's disease	0.000175	0.000633	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GAB2—Alzheimer's disease	0.000175	0.000633	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NPS—Alzheimer's disease	0.000175	0.000631	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—CALM1—Alzheimer's disease	0.000175	0.00063	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000174	0.000628	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GSK3A—Alzheimer's disease	0.000174	0.000627	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NGFR—Alzheimer's disease	0.000173	0.000624	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—F2—Alzheimer's disease	0.000172	0.000621	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—CREB1—Alzheimer's disease	0.000172	0.00062	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PTK2B—Alzheimer's disease	0.000172	0.000619	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—APP—Alzheimer's disease	0.000171	0.000617	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CRH—Alzheimer's disease	0.000171	0.000616	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ADAM10—Alzheimer's disease	0.000169	0.000609	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CCR5—Alzheimer's disease	0.000168	0.000608	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—CCL2—Alzheimer's disease	0.000168	0.000606	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SST—Alzheimer's disease	0.000167	0.000602	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GAB2—Alzheimer's disease	0.000167	0.000602	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NTRK2—Alzheimer's disease	0.000167	0.000602	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—CALM1—Alzheimer's disease	0.000166	0.0006	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GSK3A—Alzheimer's disease	0.000165	0.000597	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000165	0.000595	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—F2—Alzheimer's disease	0.000164	0.000592	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—APP—Alzheimer's disease	0.000163	0.000587	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NPS—Alzheimer's disease	0.000162	0.000584	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PLCB1—Alzheimer's disease	0.000161	0.000582	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PPP3CA—Alzheimer's disease	0.000161	0.000581	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—S100B—Alzheimer's disease	0.00016	0.000576	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—F2—Alzheimer's disease	0.000159	0.000574	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PTK2B—Alzheimer's disease	0.000159	0.000573	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—F2—Alzheimer's disease	0.000156	0.000564	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NTRK2—Alzheimer's disease	0.000154	0.000557	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SST—Alzheimer's disease	0.000154	0.000557	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GAB2—Alzheimer's disease	0.000154	0.000557	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CALM1—Alzheimer's disease	0.000154	0.000555	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PLCB1—Alzheimer's disease	0.000153	0.000554	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GSK3A—Alzheimer's disease	0.000153	0.000553	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IGF2—Alzheimer's disease	0.000152	0.000549	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APP—Alzheimer's disease	0.00015	0.000543	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NGFR—Alzheimer's disease	0.00015	0.000543	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—CREB1—Alzheimer's disease	0.000149	0.00054	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ADAM10—Alzheimer's disease	0.000147	0.00053	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IGF1R—Alzheimer's disease	0.000147	0.00053	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—CCL2—Alzheimer's disease	0.000146	0.000528	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—F2—Alzheimer's disease	0.000145	0.000522	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NGFR—Alzheimer's disease	0.000143	0.000517	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—CREB1—Alzheimer's disease	0.000142	0.000514	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PLCB1—Alzheimer's disease	0.000142	0.000513	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—LPL—Alzheimer's disease	0.000141	0.000508	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADAM10—Alzheimer's disease	0.00014	0.000505	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MEF2C—Alzheimer's disease	0.00014	0.000504	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—CCL2—Alzheimer's disease	0.000139	0.000503	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—S100B—Alzheimer's disease	0.000139	0.000502	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PRKCG—Alzheimer's disease	0.000137	0.000494	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NGF—Alzheimer's disease	0.000133	0.000482	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NGFR—Alzheimer's disease	0.000132	0.000478	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IGF2—Alzheimer's disease	0.000132	0.000478	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—S100B—Alzheimer's disease	0.000132	0.000477	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CREB1—Alzheimer's disease	0.000132	0.000475	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CCR5—Alzheimer's disease	0.00013	0.000468	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADAM10—Alzheimer's disease	0.000129	0.000467	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CCL2—Alzheimer's disease	0.000129	0.000465	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IGF1R—Alzheimer's disease	0.000128	0.000462	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HTR2A—Alzheimer's disease	0.000127	0.000458	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IGF2—Alzheimer's disease	0.000126	0.000455	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—LPL—Alzheimer's disease	0.000123	0.000443	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—S100B—Alzheimer's disease	0.000122	0.000442	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IGF1R—Alzheimer's disease	0.000122	0.000439	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MEF2C—Alzheimer's disease	0.000122	0.000439	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PRKCG—Alzheimer's disease	0.000119	0.00043	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CALM1—Alzheimer's disease	0.000119	0.000428	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—LEP—Alzheimer's disease	0.000118	0.000426	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—APOE—Alzheimer's disease	0.000118	0.000426	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CAV1—Alzheimer's disease	0.000117	0.000422	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—LPL—Alzheimer's disease	0.000117	0.000421	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IGF2—Alzheimer's disease	0.000117	0.000421	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NGF—Alzheimer's disease	0.000116	0.000419	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MEF2C—Alzheimer's disease	0.000116	0.000418	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PRKCG—Alzheimer's disease	0.000113	0.00041	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCR5—Alzheimer's disease	0.000113	0.000408	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ESR1—Alzheimer's disease	0.000113	0.000407	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IGF1R—Alzheimer's disease	0.000113	0.000407	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—F2—Alzheimer's disease	0.000111	0.000402	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HTR2A—Alzheimer's disease	0.000111	0.000399	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NGF—Alzheimer's disease	0.000111	0.000399	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NOTCH1—Alzheimer's disease	0.000109	0.000393	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—LPL—Alzheimer's disease	0.000108	0.00039	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCR5—Alzheimer's disease	0.000108	0.000388	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MEF2C—Alzheimer's disease	0.000107	0.000386	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HTR2A—Alzheimer's disease	0.000105	0.00038	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PRKCG—Alzheimer's disease	0.000105	0.000379	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CALM1—Alzheimer's disease	0.000103	0.000372	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—APOE—Alzheimer's disease	0.000103	0.000371	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—LEP—Alzheimer's disease	0.000103	0.000371	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NGF—Alzheimer's disease	0.000102	0.000369	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—GSK3B—Alzheimer's disease	0.000102	0.000369	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CAV1—Alzheimer's disease	0.000102	0.000368	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CREB1—Alzheimer's disease	0.000101	0.000366	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—INS—Alzheimer's disease	0.000101	0.000364	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCR5—Alzheimer's disease	9.95e-05	0.000359	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CCL2—Alzheimer's disease	9.93e-05	0.000358	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CALM1—Alzheimer's disease	9.82e-05	0.000354	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ESR1—Alzheimer's disease	9.81e-05	0.000354	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—APOE—Alzheimer's disease	9.78e-05	0.000353	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—LEP—Alzheimer's disease	9.78e-05	0.000353	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IGF1—Alzheimer's disease	9.76e-05	0.000352	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HTR2A—Alzheimer's disease	9.74e-05	0.000352	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CAV1—Alzheimer's disease	9.69e-05	0.00035	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—F2—Alzheimer's disease	9.69e-05	0.00035	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NOTCH1—Alzheimer's disease	9.49e-05	0.000342	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ESR1—Alzheimer's disease	9.34e-05	0.000337	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—F2—Alzheimer's disease	9.23e-05	0.000333	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CALM1—Alzheimer's disease	9.09e-05	0.000328	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—LEP—Alzheimer's disease	9.05e-05	0.000327	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APOE—Alzheimer's disease	9.05e-05	0.000327	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NOTCH1—Alzheimer's disease	9.03e-05	0.000326	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CAV1—Alzheimer's disease	8.97e-05	0.000324	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—GSK3B—Alzheimer's disease	8.9e-05	0.000321	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NOS3—Alzheimer's disease	8.85e-05	0.000319	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CREB1—Alzheimer's disease	8.83e-05	0.000319	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—INS—Alzheimer's disease	8.78e-05	0.000317	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ESR1—Alzheimer's disease	8.64e-05	0.000312	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCL2—Alzheimer's disease	8.64e-05	0.000312	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—F2—Alzheimer's disease	8.54e-05	0.000308	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IGF1—Alzheimer's disease	8.49e-05	0.000307	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—GSK3B—Alzheimer's disease	8.47e-05	0.000306	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CREB1—Alzheimer's disease	8.41e-05	0.000303	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—INS—Alzheimer's disease	8.36e-05	0.000302	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NOTCH1—Alzheimer's disease	8.36e-05	0.000302	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCL2—Alzheimer's disease	8.22e-05	0.000297	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IGF1—Alzheimer's disease	8.09e-05	0.000292	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—GSK3B—Alzheimer's disease	7.84e-05	0.000283	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CREB1—Alzheimer's disease	7.78e-05	0.000281	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—INS—Alzheimer's disease	7.73e-05	0.000279	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NOS3—Alzheimer's disease	7.7e-05	0.000278	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCL2—Alzheimer's disease	7.61e-05	0.000275	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—AKT1—Alzheimer's disease	7.58e-05	0.000274	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CASP3—Alzheimer's disease	7.51e-05	0.000271	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IGF1—Alzheimer's disease	7.48e-05	0.00027	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—IL6—Alzheimer's disease	7.46e-05	0.000269	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NOS3—Alzheimer's disease	7.33e-05	0.000265	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MAPK8—Alzheimer's disease	6.9e-05	0.000249	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—AKT1—Alzheimer's disease	6.88e-05	0.000248	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NOS3—Alzheimer's disease	6.78e-05	0.000245	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—AKT1—Alzheimer's disease	6.6e-05	0.000238	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CASP3—Alzheimer's disease	6.54e-05	0.000236	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—IL6—Alzheimer's disease	6.5e-05	0.000234	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—VEGFA—Alzheimer's disease	6.37e-05	0.00023	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—AKT1—Alzheimer's disease	6.28e-05	0.000227	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CASP3—Alzheimer's disease	6.22e-05	0.000225	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—IL6—Alzheimer's disease	6.18e-05	0.000223	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MAPK8—Alzheimer's disease	6.01e-05	0.000217	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—AKT1—Alzheimer's disease	5.99e-05	0.000216	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TGFB1—Alzheimer's disease	5.85e-05	0.000211	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—AKT1—Alzheimer's disease	5.81e-05	0.00021	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CASP3—Alzheimer's disease	5.76e-05	0.000208	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—IL6—Alzheimer's disease	5.72e-05	0.000207	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MAPK8—Alzheimer's disease	5.72e-05	0.000206	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—AKT1—Alzheimer's disease	5.7e-05	0.000206	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—VEGFA—Alzheimer's disease	5.55e-05	0.0002	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MAPK8—Alzheimer's disease	5.29e-05	0.000191	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—VEGFA—Alzheimer's disease	5.28e-05	0.000191	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—AKT1—Alzheimer's disease	5.28e-05	0.000191	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TGFB1—Alzheimer's disease	5.09e-05	0.000184	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—VEGFA—Alzheimer's disease	4.89e-05	0.000176	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TGFB1—Alzheimer's disease	4.85e-05	0.000175	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TP53—Alzheimer's disease	4.82e-05	0.000174	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TGFB1—Alzheimer's disease	4.48e-05	0.000162	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IL6—Alzheimer's disease	4.41e-05	0.000159	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TP53—Alzheimer's disease	4.19e-05	0.000151	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AKT1—Alzheimer's disease	4.07e-05	0.000147	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TP53—Alzheimer's disease	3.99e-05	0.000144	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IL6—Alzheimer's disease	3.84e-05	0.000139	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TP53—Alzheimer's disease	3.69e-05	0.000133	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IL6—Alzheimer's disease	3.65e-05	0.000132	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AKT1—Alzheimer's disease	3.54e-05	0.000128	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IL6—Alzheimer's disease	3.38e-05	0.000122	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AKT1—Alzheimer's disease	3.37e-05	0.000122	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AKT1—Alzheimer's disease	3.12e-05	0.000113	CbGpPWpGaD
